Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Conversion Ratio: Every 4 shares of issued and outstanding Common Stock will be consolidated into one share of Common Stock, ...

The Reverse Stock Split was approved by the Company's stockholders at the Company's Annual Meeting of Stockholders held on July 24, 2025 (the "Annual Meeting") to be effected in the Board's discretion ...

Common Stock to Begin Trading on Reverse-Split Adjusted Basis on January 2, 2026SAN DIEGO, CA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc.

The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, announced ...

Tobi is a crypto writer at Investopedia. He aims to simplify the complex concepts of blockchain and cryptocurrencies for the masses. Tunvarat Pruksachat / Getty Images Market watchers argue that ...

Bollinger Innovations, a struggling electric vehicle seller, is reverse-splitting its stock yet again. Bollinger was featured in a recent Barron’s piece on the swelling number of firms doing reverse ...

There’s more bad news for Tesla rival Lucid Motors. On Tuesday, shares of the luxury electric vehicle company Lucid Group (Nasdaq: LCID) fell a whopping 10% as the EV maker began trading following its ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, ...

Aptevo’s stockholders approved the reverse split at the company’s Annual Meeting on July 24, giving the Board discretion to determine the final ratio. The Board approved the 1-for-18 ratio on December ...